What is Cumberland Pharmaceuticals's EV / EBITDA?

Cumberland Pharmaceuticals (CPIX) reported EV / EBITDA of 39.2× in Q4 2025.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Cumberland Pharmaceuticals CPIX EV / EBITDA

EV / EBITDA at other companies

Baxter InternationalBAX

10.3×-1.6×

Rigel PharmaceuticalsRIGL

4.3×-1.7×

OrganonOGN

8×-1.0×

Mirum Pharmaceuticals, Inc.MIRM

1,820.6×—

ViatrisVTRS

9.6×—

BrightSpring Health Services, Inc.BTSG

19×+3.3×

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+142%

Enterprise value$90.91M+212%

P/S2.3×+1.4×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Calculated from Cumberland Pharmaceuticals’s reported figures.

enterprise value/ebitda=39.2×

Based on the most recent quarter.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's EV / EBITDA?: Cumberland Pharmaceuticals (CPIX) reported EV / EBITDA of 39.2× in Q4 2025.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.